Loading clinical trials...
Loading clinical trials...
Open-Label, Single-Arm, Phase 3 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
Conditions
Interventions
fenfluramine
Locations
12
United States
Ep0213 105
Memphis, Tennessee, United States
Ep0213 107
Dallas, Texas, United States
Ep0213 103
Seattle, Washington, United States
Ep0213 502
Brussels, Belgium
Ep0213 501
Edegem, Belgium
Ep0213 303
Bielefeld, Germany
Start Date
May 21, 2024
Primary Completion Date
September 3, 2026
Completion Date
December 16, 2026
Last Updated
April 3, 2026
NCT06872125
NCT05419492
NCT04462770
NCT06401538
NCT06598449
NCT06504511
Lead Sponsor
UCB BIOSCIENCES, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions